PO.MCB03.03 · 分子与细胞生物学

泛素连接酶HUWE1调控beta-catenin在WNT信号传导与细胞黏附功能之间的平衡

The ubiquitin ligase HUWE1 controls the balance between beta-catenin functions in WNT signaling and cell adhesion

海报缩略图:泛素连接酶HUWE1调控beta-catenin在WNT信号传导与细胞黏附功能之间的平衡
编号 591 展板 29 时间 4/19 02:00–05:00 区域 Section 24 主讲 Caleb Sinclear, BS;M Phil;PhD
分会场 Tumor Cell Plasticity, Microenvironment, and Stress-Response Pathways
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Caleb Kwame Sinclear, Joseph McKenna, Yalan Wu, Praveen Sonkusre, Andres M. Lebensohn

Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NIH-NCI, Bethesda, MD

摘要 Abstract

中文摘要
beta-catenin在细胞中发挥两大主要作用:一是作为细胞质和细胞核中WNT信号转录反应的关键介导者,二是作为黏附连接(即质膜处的细胞间黏附复合体)的结构组分。beta-catenin这两个空间上分隔、功能上不同的库之间的平衡如何受到调控,目前尚不十分清楚。WNT/beta-catenin信号是一条基础性信号通路,其失调可驱动多种类型的癌症。黏附连接的解体(常由beta-catenin减少引起)是上皮-间质转化(EMT)的标志之一,而EMT是一个促进癌症转移的过程。本研究的目的是探究调控beta-catenin这两个空间上和功能上不同库之间平衡的机制。在WNT/beta-catenin信号传导过程中,主要受调控的步骤是由降解复合体介导的beta-catenin磷酸化与降解,该复合体由支架蛋白APC和AXIN1/2以及激酶casein kinase 1alpha和GSK3alpha/beta组成。我们利用CRISPR从人单倍体(HAP1)细胞构建了两个疾病模型细胞系:1. casein kinase 1alpha敲除细胞;2. beta-catenin ST-A细胞,其beta-catenin含有使其对降解复合体的磷酸化和降解不敏感的突变。在这两个细胞系中,我们通过共聚焦显微镜观察到beta-catenin在细胞质和细胞核中积累,并促进WNT信号的过度活化。重要的是,我们发现,在casein kinase 1alpha敲除细胞中缺失E3泛素连接酶HUWE1可诱导beta-catenin定位发生显著变化,从细胞核转移到质膜,同时伴随WNT/beta-catenin信号的大幅减弱。通过邻近连接实验以及我们开发的一种新的依赖黏附连接的细胞黏附实验,我们发现HUWE1缺失导致的beta-catenin向质膜定位促进了beta-catenin并入黏附连接,并增强了其对细胞间黏附的功能性贡献。在含有不可降解beta-catenin的beta-catenin ST-A细胞中,同样观察到HUWE1对beta-catenin亚细胞定位的调控。综上所述,这些结果表明HUWE1调控beta-catenin在WNT信号中的转录活性与其细胞黏附功能之间的平衡。因此,通过HUWE1调控beta-catenin功能,可能为由WNT信号过度活化引起的癌症和/或由EMT驱动的转移开辟新的治疗途径。
查看英文原文 English abstract
beta-catenin plays two major roles in the cell, one as the key mediator of transcriptional responses to WNT signaling in the cytoplasm and nucleus, and the other as a structural component of adherens junctions, cell-cell adhesion complexes at the plasma membrane. How the balance between these spatially separate and functionally distinct pools of beta-catenin is controlled is not well understood. WNT/beta-catenin signaling is a fundamental signaling pathway, dysregulation of which can drive many types of cancer. Disassembly of adherens junctions, often caused by reduced beta-catenin, is a hallmark of epithelial-mesenchymal transition (EMT), a process that promotes cancer metastasis. The goal of this study was to investigate the mechanisms that regulate the balance between the two spatially and functionally distinct pools of beta-catenin. During WNT/beta-catenin signaling, the main regulated step is beta-catenin phosphorylation and degradation mediated by the destruction complex, composed of the scaffold proteins APC and AXIN1/2, and the kinases casein kinase 1alpha and GSK3alpha/beta. Using CRISPR, we created two disease model cell lines from haploid human (HAP1) cells: 1. casein kinase 1alpha knock-out cells, and 2. beta-catenin ST-A cells, containing mutations in beta-catenin that render it insensitive to phosphorylation and degradation by the destruction complex. In both cell lines, we observed by confocal microscopy that beta-catenin accumulates in the cytoplasm and the nucleus, and promotes hyperactive WNT signaling. Importantly, we found that loss of the E3 ubiquitin ligase HUWE1 in casein kinase 1alpha knock-out cells induced a marked change in the localization of beta-catenin from the nucleus to the plasma membrane, which was accompanied by a substantial reduction in WNT/beta-catenin signaling. Through proximity ligation assays and a new adherens junction-dependent cell adhesion assay that we developed, we found that localization of beta-catenin to the plasma membrane caused by HUWE1 loss promotes beta-catenin incorporation into adherens junctions and increases its functional contribution to cell-cell adhesion. In beta-catenin ST-A cells that contain non-degradable beta-catenin, regulation of beta-catenin subcellular localization by HUWE1 was also observed. Taken together, these results demonstrate that HUWE1 regulates the balance between beta-catenin transcriptional activity in WNT signaling and its cell adhesion functions. Therefore, regulation of beta-catenin functions through HUWE1 may open new therapeutic avenues for cancers caused by hyperactive WNT signaling, and/or in metastasis driven by EMTs.
利益披露 Disclosure
C. K. Sinclear, None.. J. McKenna, None.. Y. Wu, None.. P. Sonkusre, None.. A. M. Lebensohn, None.

← 返回 AACR 2026 检索